Genes Associated with Addiction: Alcoholism, Opiate, and Cocaine Addiction

NeuroMolecular Medicine

Volumn 5, Issue 1, 2004, Pages 85-108

  Kreek, Mary Jeanne ^a   Nielsen, David A ^a   LaForge, K Steven ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

Addiction; Alcohol; Cocaine; Genetics; Genotype; Opiate; Physiogenetics; Physiogenomics; Polymorphism; Single nucleotide polymorphism

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ALCOHOL; ALCOHOL DEHYDROGENASE; AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CATECHOL METHYLTRANSFERASE; COCAINE; CYTOCHROME P450 2D6; DOPAMINE 4 RECEPTOR; DOPAMINE BETA MONOOXYGENASE; DOPAMINE TRANSPORTER; FATTY ACID AMIDASE; MORPHINE 6 GLUCURONIDE; MU OPIATE RECEPTOR; NALOXONE; NEUROPEPTIDE Y; OPIATE; PHORBOL 13 ACETATE 12 MYRISTATE; PREPRODYNORPHIN; SEROTONIN 1B RECEPTOR; SEROTONIN 2A RECEPTOR; SEROTONIN TRANSPORTER; TRANSCRIPTION FACTOR AP 1; TRYPTOPHAN HYDROXYLASE;

ALCOHOLISM; COCAINE DEPENDENCE; DRUG DEPENDENCE; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; OPIATE ADDICTION; PRIORITY JOURNAL; REVIEW;

EID: 1642299385     PISSN: 15351084     EISSN: None     Source Type: Journal    
DOI: 10.1385/nmm:5:1:085     Document Type: Review

References (172)

1. Alexander, R. C., Heydt, D., Ferraro, T. N., Vogel, W., Berrettini, W. H. (1996) Further evidence for a quantitative trait locus on murine chromosome 10 controlling morphine preference in inbred mice. Psychiatr. Genet. 6, 29-31.
2. Alván, G., Bechtel, P., Iselius, L., Gundert-Remy, U. (1990) Hydroxylation polymorphisms of debrisoquine and mephenytoin in European populations. Eur. J. Clin. Pharmacol. 39, 533-537.
3. Asghari, V., Sanyal, S., Buchwaldt, S., Paterson, A., Jovanovic, V., Van Tol, H. H. (1995) Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J. Neurochem. 65, 1157-1165.
4. Aubert, R., Betoulle, D., Herbeth, B., Siest, G., Fumeron, F. (2000) 5-HT2A receptor gene polymorphism is associated with food and alcohol intake in obese people. Int. J. Obes. Relat. Metab. Disord. 24, 920-924.
5. Barnard, E. A., Skolnick, P., Olsen, R. W., et al. (1998) International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acid A receptors: classification on the basis of subunit structure and receptor function. Pharmacol. Rev. 50, 291-313.
6. Becker, A., Grecksch, G., Brodemann, R., et al. (2000) Morphine self-administration in mu-opioid receptor-deficient mice. Naunyn-Schmiedebergs Arch. Pharmacol. 361, 584-589.
7. Becker, A., Grecksch, G., Kraus, J., Loh, H. H., Schroeder, H., Hollt, V. (2002) Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice. Naunyn-Schmiedebergs Arch. Pharmacol. 365, 296-302.
8. Befort, K., Filliol, D., Decaillot, F. M., Gaveriaux-Ruff, C., Hoehe, M. R., Kieffer, B. L. (2001) A single nucleotide polymorphic mutation in the human mu opioid receptor severely impairs receptor signaling. J. Biol. Chem. 276, 3130-3137.
9. Belknap, J. K., and Crabbe, J. C. (1992) Chromosome mapping of gene loci affecting morphine and amphetamine responses in BXB recombinant inbred mice. Ann. NY. Acad. Sci. 654, 311-323.
10. Bergen, A. W., Kokoszka, J., Peterson, R., et al. (1997) Mu opioid receptor gene variants: lack of association with alcohol dependence. Mol. Psychiatry 2, 490-494.
11. Berrettini, W. H., Ferraro, T. N., Alexander, A. C., Buchberg, A. M., Vogel, W. H. (1994) Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains. Nat. Genet. 7, 54-58.
12. Berrettini, W. H., Hoehe, M. R., Ferrada, T. N., Gottheil, E. (1997) Human mu opioid receptor gene polymorphisms and vulnerability to substance abuse. Addict. Biol. 2, 303-308.
13. Bierut, L. J., Dinwiddie, S. H., Begleiter, H., et al. (1998) Familial transmission of substance dependence: alcohol, marijuana, cocaine, and habitual smoking: a report from the Collaborative Study on the Genetics of Alcoholism. Arch. Gen. Psychiatry 55, 982-988.
14. Bond, C., LaForge, K. S., Tian, M., et al. (1998) Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc. Natl. Acad. Sci. USA. 95, 9608-9613.
15. Bosron, W. F., Ehrig, T., Li, T. K. (1993) Genetic factors in alcohol metabolism and alcoholism. Semin. Liver Dis. 13, 126-135.
16. Boyle, A. E., Segal, R., Smith, B. R., Amit, Z. (1993) Bidirectional effects of GABAergic agonists and antagonists on maintenance of voluntary ethanol intake in rats. Pharmacol. Biochem. Behav. 46, 179-182.
17. Brunner, H. G., Nelen, M., Breakefield, X. O., Ropers, H. H., van Oost, B. A. (1993) Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262, 578-580.
18. Carr, L. G., Foroud, T., Stewart, T., Castelluccio, P., Edenberg, H. J., Li, T. K. (2002) Influence of ADH1B polymorphism on alcohol use and its subjective effects in a Jewish population. Am. J. Med. Genet. 112, 138-143.
19. Cases, O., Seif, I., Grimsby, J., et al. (1995) Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268, 1763-1766.
20. Chang, Y. T., Sun, H. S., Fann, C. S., et al. (2002) Association of the gamma-aminobutyric acid A receptor gene cluster with alcohol dependence in Taiwanese Han. Mol. Psychiatry 7, 828-829.
21. Chen, A. C. H., LaForge, K. S., Ho, A., et al. (2002) Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse. Am. J. Med. Genet. 114, 429-435.
22. Chen, W. J., Loh, E. W., Hsu, Y. P., Chen, C. C., Yu, J. M., Cheng, A. T. (1996) Alcohol-metabolising genes and alcoholism among Taiwanese Han men: independent effect of ADH2, ADH3 and ALDH2. Br. J. Psychiatry 168, 762-767.
23. 1-17 reduces extracellular dopamine levels in the nucleus accumbens. In Harris, L. S. (ed.), Problems of Drug Dependence, 1996; Proceedings of the 58th Annual Scientific Meeting of the College on Problems of Drug Dependence. National Institute of Drug Abuse Research Monograph Series, 174 (p. 113). Washington, DC: U.S. Government Printing Office. DHHS Pub. No.: (ADM)97-4236.
24. Cloninger, R., Bohman, M., Sigvardsson, S. (1981) Inheritance of alcohol abuse: cross-fostering analysis of adopted men. Arch. Gen. Psychiatry 38, 861-868.
25. Comings, D. E., Gonzalez, N., Wu, S., et al. (1999) Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse. Am. J. Med. Genet. 88, 358-368.
26. Crabb, D. W., Dipple, K. M., Thomasson, H. R. (1993) Alcohol sensitivity, alcohol metabolism, risk of alcoholism, and the role of alcohol and aldehyde dehydrogenase genotypes. J. Lab. Clin. Med. 122, 234-240.
27. Crabb, D. W., Edenberg, H. J., Bosron, W. F., Li, T. K. (1989) Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant. J. Clin. Invest. 83, 314-316.
28. Crabbe, J. C., Phillips, T. J., Feller, D. J., et al. (1996) Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors. Nat. Genet. 14, 98-101.
29. Cravatt, B. F., Demarest, K., Patricelli, M. P., et al. (2001) Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. USA. 98, 9371-9376.
30. Cubells, J. F., van Kammen, D. P., Kelley, M. E., et al. (1998) Dopamine β-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum. Genet. 102, 533-540.
31. Cubells, J. F., Kranzler, H. R., McCance-Katz, E., et al. (2000) A haplotype at the DBH locus, associated with low plasma dopamine β-hydroxylase activity, also associates with cocaine-induced paranoia. Mol. Psychiatry 5, 56-63.
32. Dálen, P., Frengell, C., Dahl, M. L., Sjoqvist, F. (1997) Quick onset of severe abdominal pain after codeine in an ultrarapid metabolizer of debrisoquine. Ther. Drug Monit. 19, 543-544.
33. Daly, A. K., Brockmoller, J., Broly, F., et al. (1996) Nomenclature for human CYP2D6 alleles. Pharmacogenetics 6, 193-201.
34. Edenberg, H. J. (2002) The collaborative study on the genetics of alcoholism: an update. Alcohol Res. Health 26, 214-218.
35. Ehlers, C. L., Carr, L., Betancourt, M., Montane-Jaime, K. (2003) Association of the ADH2*3 allele with greater alcohol expectancies in African-American young adults. J. Stud. Alcohol 64, 176-181.
36. Ehlers, C. L., Gilder, D. A., Harris, L., Carr, L. (2001) Association of the ADH2*3 allele with a negative family history of alcoholism in African American young adults. Alcohol. Clin. Exp. Res. 25,1773-1777.
37. Ekelund, J., Lichtermann, D., Jarvelin, M. R., Peltonen, L. (1999). Association between novelty seeking and the type 4 dopamine receptor gene in a large Finnish cohort sample. Am. J. Psychiatry 156, 1453-1455.
38. Fehr, C., Grintschuk, N., Szegedi, A., et al. (2000) The HTR1B 861G>C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy. Psychiatry Res. 97, 1-10.
39. Fernandes, L. C., Kilicarslan, T., Kaplan, H. L., Tyndale, R. F., Sellers, E. M., Romach, M. K. (2002) Treatment of codeine dependence with inhibitors of cytochrome P450 2D6. J. Clin. Psychopharmacol. 22, 326-329.
40. Foroud, T., Edenberg, H. J., Goate, A., et al. (2000) Alcoholism susceptibility loci: confirmation studies in a replicate sample and further mapping. Alcohol. Clin. Exp. Res. 24, 933-945.
41. Franke, P., Nothen, M. M., Wang, T., et al. (2000) DRD4 exon III VNTR polymorphism-susceptibility factor for heroin dependence? Results of a case-control and a family-based association approach. Mol. Psychiatry 5, 101-104.
42. Franke, P., Wang, T., Nöthen, M. K., et al. (2001) Nonreplication of association between μ-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence. Am. J. Med. Genet. 105, 114-119.
43. Fuke, S., Suo, S., Takahashi, N., Koike, H., Sasagawa, N., Ishiura, S. (2001) The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics J. 1, 152-156.
44. Gaedigk, A., Blum, M., Gaedigk, R., Eichelbaum, M., Meyer U. A. (1991) Deletion of the entire cytochrome P450 CYP2D6 gene as a cause of impaired drug metabolism in poor metabolizers of the debrisoquine/sparteine polymorphism. Am. J. Hum. Genet. 48, 943-950.
45. Gelernter, J., Kranzler, H., Coccaro, E., Siever, L., New, A., Mulgrew, C. L. (1997) D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects. Am. J. Hum. Genet. 61, 1144-1152.
46. Gelernter, J., Kranzler, H., Cubells, J. (1999) Genetics of two mu opioid receptor gene (OPRM1) exon 1 polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects. Mol. Psychiatry 4, 476-483.
47. Genet. Epidemiol. (1999) 17(suppl 1),
48. George, S. R., Cheng, R., Nguyen, T., Israel, Y., O'Dowd, B. F. (1993) Polymorphisms of the D4 dopamine receptor alleles in chronic alcoholism. Biochem. Biophys. Res. Comm. 196, 107-114.
49. Glatt, S. J., Faraone, S. V., Tsuang, M. T. (2003) Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. Am. J. Psychiatry 160, 469-476.
50. Gough, A. C., Miles, J. S., Spurr, N. K., et al. (1990) Identification of the primary gene defect at the cytochrome P450 CYP2D locus. Nature 347, 773-776.
51. Grobin, A. C., Matthews, D. B., Devaud, L. L., Morrow, A. L. (1998) The role of GABA(A) receptors in the acute and chronic effects of ethanol. Psychopharmacol. (Berl.) 139, 2-19.
52. Hall, F. S., Sora, I., Uhl, G. R. (2001) Ethanol consumption and reward are decreased in mu-opiate receptor knockout mice. Psychopharmacology 154, 43-49.
53. Harada, S., Agarwal, D. P., Goedde, H. W., Tagaki, S., Ishikawa, B. (1982) Possible protective role against alcoholism for aldehyde dehydrogenase isozyme deficiency in Japan. Lancet 2, 827.
54. Harada, S., Misawa, S., Agarwal, D. P., Goedde, H. W. (1980). Liver alcohol dehydrogenase and aldehyde dehydrogenase in the Japanese: isozyme variation and its possible role in alcohol intoxication. Am. J. Hum. Genet. 32, 8-15.
55. Hernandez-Avila, C. A., Wand, G., Luo, X., Gelernter, J., Kranzler, H. R. (2003) Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1). Am. J. Med. Genet. 118B, 60-65.
56. Higuchi, S., Matsushita, S., Muramatsu, T., Murayama, M., Hayashida, M. (1996) Alcohol and aldehyde dehydrogenase genotypes and drinking behavior in Japanese. Alcohol. Clin. Exp. Res. 20, 493-497.
57. Higuchi, S., Muramatsu, T., Shigemori, K., et al. (1992) The relationship between low Km aldehyde dehydrogenase phenotype and drinking behavior in Japanese. J. Stud. Alcohol 53, 170-175.
58. Hoehe, M. R., Kopke, K., Wendel, B., et al. (2000) Sequence variability and candidate gene analysis in complex diseases: association of μ opioid receptor gene variation with substance dependence. Hum. Mol. Genet. 9, 2895-2908.
59. Holmes, A., Murphy, D. L., Crawley, J. N. (2002) Reduced aggression in mice lacking the serotonin transporter. Psychopharmacol. (Berl.) 161, 160-167.
60. Horikawa, S., Takai, T., Toyosato, M., et al. (1983) Isolation and structural organization of the human preproenkephalin B gene. Nature 306, 611-614.
61. Hsu, Y. P., Loh, E. W., Chen, W. J., Chen, C. C., Yu, J. M., Cheng, A. T. (1996) Association of monoamine oxidase A alleles with alcoholism among male Chinese in Taiwan. Am. J. Psychiatry 153,1209-1211.
62. Hsu, Y. P., Tai, J. J., Seow, S. V., Chen, C. C., Yu, J. M., Cheng, A. T. (1998) Allelic association of tryptophan hydroxylase with alcoholism in five Taiwanese ethnic groups. Mol. Psychiatry 3, 213-214.
63. Huang, Y. Y., Grailhe, R., Arango, V., Hen, R., Mann, J. J. (1999) Relationship of psychopathology to the human serotonin1B genotype and receptor binding kinetics in postmortem brain tissue. Neuropsychopharmacology 21, 238-246.
64. Hutchison, K. E., McGeary, J., Smolen, A., Bryan, A., Swift, R. M. (2002) The DRD4 VNTR polymorphism moderates craving after alcohol consumption. Health Psychol. 21, 139-146.
65. Ikawa, M., Impraim, C. C., Wang, G., Yoshida, A. (1983). Isolation and characterization of aldehyde dehydrogenase isozymes from usual and atypical human livers. J. Biol. Chem. 258, 6282-6287.
66. Ilveskoski, E., Kajander, O. A., Lehtimaki, T., et al. (2001) Association of neuropeptide y polymorphism with the occurrence of type 1 and type 2 alcoholism. Alcohol Clin. Exp. Res. 25, 1420-1422.
67. Ishiguro, H., Saito, T., Shibuya, H., Toru, M., Arinami, T. (1999) The 5′ region of the tryptophan hydroxylase gene: mutation search and association study with alcoholism. J. Neural. Transm. 106,1017-1025.
68. Johansson, I., Lundqvist, E., Bertilsson, L., Dahl, M. L., Sjoqvist, F., Ingelman-Sundberg, M. (1993) Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultra-rapid metabolism of debrisoquine. Proc. Natl. Acad. Sci. USA. 90, 11825-11829.
69. Jonsson, E. G., Goldman, D., Spurlock, G., et al. (1997) Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Eur. Arch. Psychiatry Clin. Neurosci. 247, 297-302.
70. Joober, R., Gauthier, J., Lal, S., et al. (2002) Catechol-O-methyltransferase Val-108/158-Met gene variants associated with performance on the Wisconsin Card Sorting Test. Arch. Gen. Psychiatry 59,662-663.
71. Kagimoto, M., Heim, M., Kagimoto, K., Zeugin, T., Meyer, U. A. (1990) Multiple mutations of the human cytochrome P450IID6 gene (CYP2D6) in poor metabolizers of debrisoquine. Study of the functional significance of individual mutations by expression of chimeric genes. J. Biol. Chem. 265, 17209-17214.
72. Kaij, L. (1960) Alcoholism in Twins: Studies on the Etiology and Sequels of Abuse and Alcohol., Almqvist & Wiksell, Stockholm.
73. Karvonen, M. K., Pesonen, U., Koulu, M., et al. (1998) Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels. Nat. Med. 4, 1434-1437.
74. Kathiramalainathan, K., Kaplan, H. L., Romach, M. K., et al. (2000) Inhibition of cytochrome P450 2D6 modifies codeine abuse liability. J. Clin. Psychopharmacol. 20, 435-444.
75. Kauhanen, J., Hallikainen, T., Tuomainen, T. P., et al. (2000a) Association between the functional polymorphism of catechol-O-methyltransferase gene and alcohol consumption among social drinkers. Alcohol. Clin. Exp. Res. 24, 135-139.
76. Kauhanen, J., Karvonen, M. K., Pesonen, U., et al. (2000b) Neuropeptide Y polymorphism and alcohol consumption in middle-aged men. Am. J. Med. Genet. 93, 117-121.
77. Kendler, K. S., Jacobson, K. C., Prescott, C. A., Neale, M. C. (2003) Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants, and opiates in male twins. Am. J. Psychiatry 160, 687-695.
78. Kitanaka, N., Sora, I., Kinsey, S., Zeng, Z., Uhl, G. R. (1998) No heroin or morphine 6 beta-glucuronide analgesia in mu-opioid receptor knockout mice. Eur. J. Pharmacol. 355, R1-R3.
79. Koch, T., Kroslak, T., Averbeck, M., et al. (2000). Allelic variation S268P of the human mu-opioid receptor affects both desensitization and G protein coupling. Mol. Pharmacol. 58, 328-334.
80. Kotler, M., Cohen, H., Segman, R., et al. (1997) Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Mol. Psychiatry 2, 251-254.
81. Kozak, C. A., Fillie, J., Adamson, M. C., Chen, Y., Yu, L. (1994) Murine chromosomal location of the mu and kappa opioid receptor genes. Genomics 21, 659-661.
82. Kranzler, H., Lappalainen, J., Nellissery, M., Gelernter, J. (2002) Association study of alcoholism subtypes with a functional promoter polymorphism in the serotonin transporter protein gene. Alcohol. Clin. Exp. Res. 26, 1330-1335.
83. Kreek, M. J. (1996) Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases. Neurochem. Res. 21, 1469-1488.
84. Kreek, M. J. (2000) Opiates, opioids, SNP's and the addictions: Nathan B. Eddy Memorial Award for lifetime excellence in drug abuse research lecture. In Harris, L. S. (ed.), Problems of Drug Dependence, 1999; Proceedings of the 61st Annual Scientific Meeting of the College on Problems of Drug Dependence. National Institute of Drug Abuse Research Monograph Series, 180 (pp. 3-22). Washington, DC: U.S. Government Printing Office. DHHS Pub. No. (ADM)00-4737.
85. Kreek, M. J., LaForge, K. S., Butelman, E. (2002a) Pharmacotherapy of addictions. Nat. Rev. Drug Discov. 1, 710-726.
86. Kreek, M. J. (2002b) Gene diversity in the endorphin system: SNPs, chips and possible implications. In Yudell, M., and DeSalle, R. (eds.) (pp. 97-108), The Genomic Revolution: Unveiling the Unity of Life. National Academy Press/Joseph Henry Press, Washington, DC.
87. LaForge, K. S., Yuferov, V., Kreek, M. J. (2000) Opioid receptor and peptide gene polymorphisms: potential implications for addictions. Eur. J. Pharmacol. 410, 249-268.
88. Lappalainen, J., Kranzler, H. R., Malison, R., et al. (2002) A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States. Arch. Gen. Psychiatry 59, 825-831.
89. Lappalainen, J., Long, J. C., Eggert, M., et al. (1998) Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. Arch. Gen. Psychiatry 55, 989-994.
90. Lesch, K. P., Bengel, D., Heils, A., et al. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1531.
91. Li, T., Liu, X., Zhu, Z. H., et al. (2000) Association analysis of polymorphisms in the mu opioid gene and heroin abuse in Chinese subjects. Addict. Biol. 5, 181-186.
92. Li, T., Xu, K., Deng, H., et al. (1997) Association analysis of the dopamine D4 gene exon III VNTR and heroin abuse in Chinese subjects. Mol. Psychiatry 2, 413-416.
93. Long, J. C., Knowler, W. C., Hanson, R. L., et al. (1998) Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population. Am. J. Med. Genet. 81, 216-221.
94. Lötsch, J., Sharke, C., Grösch, S., Darimont, J., Schmidt, H., Geisslinger, G. (2002) The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine. Pharmacogenetics 4, 3-9.
95. Mattay, V. S., Goldberg, T. E., Fera, F., et al. (2003) Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc. Natl. Acad. Sci. USA. 100, 6186-6191.
96. Matthes, H. W. D., Maldonado, R., Simonin, F., et al. (1996) Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the μ opioid receptor gene. Nature 383, 819-823.
97. McCreadie, R. G. (2002) Use of drugs, alcohol and tobacco by people with schizophrenia: case-control study. Br. J. Psychiatry 181, 321-325.
98. Merikangas, K. R., Stolar, M., Stevens, D. E., et al. (1998) Familial transmission of substance use disorders. Arch. Gen. Psychiatry 55, 973-979.
99. Meroz, Y., Davidson, E. M., Shir, Y., Caraco, Y. (2001) Variable response to alfentanil due to genetic polymorphism. Anesthesiology 95, A1358.
100. Mizoi, Y., Tatsuno, Y., Adachi, J., et al. (1983) Alcohol sensitivity related to polymorphism of alcohol-metabolizing enzymes in Japanese. Pharmacol. Biochem. Behav. 18(Suppl 1), 127-133.
101. Muramatsu, T., Higuchi, S. (1995) Dopamine transporter gene polymorphism and alcoholism. Biochem. Biophys. Res. Comm. 211, 28-32.
102. Muramatsu, T., Higuchi, S., Murayama, M., Matsushita, S., Hayashida, M. (1996) Association between alcoholism and the dopamine D4 receptor gene. J. Med. Genet. 33, 113-115.
103. Nakamura, K., Iwahashi, K., Matsuo, Y., Miyatake, R., Ichikawa, Y., Suwaki, H. (1996) Characteristics of Japanese alcoholics with the atypical aldehyde dehydrogenase 2*2. I. A comparison of the genotypes of ALDH2, ADH2, ADH3, and cytochrome P-4502E1 between alcoholics and nonalcoholics. Alcohol. Clin. Exp. Res. 20, 52-55.
104. Nestler, E. J. (2000) Genes and addiction. Nat. Genet. 26, 277-281.
105. Nielsen, D. A., Dean, M., Goldman, D. (1992) Genetic mapping of the human tryptophan hydroxylase gene on chromosome 11, using an intronic conformational polymorphism. Am. J. Hum. Genet. 51, 1366-1371.
106. Nielsen, D. A., Goldman, D., Virkkunen, M., Tokola, R., Rawlings, R., Linnoila, M. (1994) Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch. Gen. Psychiatry 51, 34-38.
107. Nielsen, D. A., Virkkunen, M., Lappalainen, J., et al. (1998) A tryptophan hydroxylase gene marker for suicidality and alcoholism. Arch. Gen. Psychiatry 55, 593-602.
108. O'Malley, S. S., Krishnan-Sarin, S., Farren, C., Sinha, R., Kreek, M. J. (2002) Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamopituitary-adrenocortical axis. Psychopharmacol. (Berl.) 160, 19-29.
109. Ono, H., Shirakawa, O., Kitamura, N., et al. (2002) Tryptophan hydroxylase immunoreactivity is altered by the genetic variation in postmortem brain samples of both suicide victims and controls. Mol. Psychiatry 7, 1127-1132.
110. Oscarson, M., Hidestrand, M., Johansson, I., Ingelman-Sundberg, M. (1997) A combination of mutations in the CYP2D6*17 (CYP2D6Z) allele causes alterations in enzyme function. Mol. Pharmacol. 52, 1034-1040.
111. Osier, M., Pakstis, A. J., Kidd, J. R., et al. K. (1999) Linkage disequilibrium at the ADH2 and ADH3 loci and risk of alcoholism. Am. J. Hum. Genet. 64, 1147-1157.
112. Oslin, D. W., Berrettini, W., Kranzler, H. R., et al. (2003) A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology 28, 1546-1552.
113. Oxenstierna, G., Edman, G., Iselius, L., Oreland, L., Ross, S. B., Sedvall, G. (1986) Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals-a genetic study. J. Psychiat. Res. 20, 19-29.
114. Palmatier, M. A., Kang, A. M., Kidd, K. K. (1999) Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol. Psychiatry 46, 557-567.
115. Parsian, A., Cloninger, C. R., Sinha, R., Shang, S. H. (2003) Functional variation in promoter region of monoamine oxidase A and subtypes of alcoholism: haplotype analysis. Am. J. Med. Genet. 117B, 46-50.
116. Parsian, A., Zhang, Z. H. (1999) Human chromosomes 11p15 and 4p12 and alcohol dependence: possible association with the GABRB1 gene. Am. J. Med. Genet. 88, 533-538.
117. Partanen, J., Bruun, K., Markkanen, T. (1966) Inheritance of Drinking Behavior: A Study on Intelligence, Personality, and Use of Alcohol of Adult Twins. The Finnish Foundation for Alcohol Studies, Helsinki.
118. Poulsen, L., Brøsen, K., Arendt-Nielsen, L., Gram, L. F., Elbæk, K., Sindrup, S. H. (1996) Codeine and morphine in extensive and poor metabolizers of sparteine: pharmacokinetics, analgesic effect and side effects. Eur. J. Clin. Pharmacol. 51, 289-295.
119. Reich, T., Edenberg, H. J., Goate, A., et al. (1998) Genome-wide search for genes affecting the risk for alcohol dependence. Am. J. Med. Genet. 81, 207-215.
120. Roberts, A. J., McDonald, J. S., Heyser, C. J., et al. (2000) mu-opioid receptor knockout mice do not self-administer alcohol. J. Pharmacol. Exp. Ther. 293, 1002-1008.
121. Romach, M. K., Otton, S. V., Somer, G., Tyndale, R. F., Sellers, E. M. (2000) Cytochrome P450 2D6 and treatment of codeine dependence. J. Clin. Psychopharmacol. 20, 43-45.
122. Sabol, S. Z., Hu, S., Hamer, D. (1998) A functional polymorphism in the monoamine oxidase A gene promoter. Hum. Genet. 103, 273-279.
123. Samochowiec, J., Lesch, K. P., Rottmann, M., et al. (1999) Association of a regulatory polymorphism in the promoter region of the monoamine oxidase A gene with antisocial alcoholism. Psychiatry Res. 86, 67-72.
124. Sander, T., Samochowiec, J., Ladehoff, M., et al. (1999) Association analysis of exonic variants of the gene encoding the GABAB receptor and alcohol dependence. Psychiatr. Genet. 9, 69#-373.
125. Schinka, J. A., Town, T., Abdullah, L., et al. (2002) A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances. Mol. Psychiatry 7, 224-228.
126. Schluger, J. H., Ho, A., Borg, L., et al. (1998) Nalmefene causes greater hypothalamic-pituitary-adrenal axis activation than naloxone in normal volunteers: implications for the treatment of alcoholism. Alcohol. Clin. Exp. Res. 22, 1430-1436.
127. Shea, S. H., Wall, T. L., Carr, L. G., Li, T. K. (2001) ADH2 and alcohol-related phenotypes in Ashkenazic Jewish American college students. Behav. Genet. 31, 231-239.
128. Shen, Y. C., Fan, J. H., Edenberg, H. J., et al. (1997) Polymorphism of ADH and ALDH genes among four ethnic groups in China and effects upon the risk for alcoholism. Alcohol. Clin. Exp. Res. 21, 1272-1277.
129. Shi, J., Jui, L., Xu, Y., Wang, F., Huang, W., Hu, G. (2002) Sequence variation in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Human Mut. 19, 459-460.
130. Silva, A. P., Cavadas, C., Grouzmann, E. (2002) Neuropeptide Y and its receptors as potential therapeutic drug targets. Clin. Chim. Acta 326, 3-25.
131. Sindrup, S. H., Brosen, K., Bjerring, P., et al. (1990) Codeine increases pain thresholds to copper vapor laser stimuli in extensive but not poor metabolizers of sparteine. Clin. Pharmacol. Ther. 48, 686-693.
132. Sipe, J. C., Chiang, K., Gerber, A. L., Beutler, E., Cravatt, B. F. (2002) A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc. Natl. Acad. Sci. USA. 99, 8394-8399.
133. Skarke, C., Darimont, J., Schmidt, H., Geisslinger, G., Lötsch, J. (2003) Analgesic effects of morphine and morphine-6-glucuronide in a transcutaneous electrical pain model in healthy volunteers. Clin. Pharmacol. Ther. 73, 107-121.
134. Sora, I., Takahashi, N., Funada, M., et al. (1997) Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. USA. 94, 1544-1549.
135. Spielman, R. S., and Weinshilboum, R. M. (1981) Genetics of red cell COMT activity: analysis of thermal stability and family data. Am. J. Med. Genet. 10, 279-290.
136. Stallings, M. C., Corley, R. P., Hewitt, J. K., et al. (2003) A genome-wide search for quantitative trait loci influencing substance dependence vulnerability in adolescence. Drug Alcohol Depend. 70, 295-307.
137. Szeto, C. Y., Tang, N. L., Lee, D. T., Stadlin, A. (2001) Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts. Neuroreport 12, 1103-1106.
138. Takeshita, T., Morimoto, K., Mao, X., Hashimoto, T., Furuyama, J. (1994) Characterization of the three genotypes of low Km aldehyde dehydrogenase in a Japanese population. Hum. Genet. 94, 217-223.
139. Tan, E.-C., Tan, C.-H., Karupathivan, U., Yap, E. P. H. (2003) Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport 14, 569-572.
140. Thiele, T. E., Marsh, D. J., Ste Marie, L., Bernstein, I. L., Palmiter, R. D. (1998) Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 396, 366-369.
141. Thomasson, H. R., Crabb, D. W., Edenberg, H. J., Li, T. K. (1993) Alcohol and aldehyde dehydrogenase polymorphisms and alcoholism. Behav. Genet. 23, 131-136.
142. Thomasson, H. R., Crabb, D. W., Edenberg, H. J., et al. (1994) Low frequency of the ADH2*2 allele among Atayal natives of Taiwan with alcohol use disorders. Alcohol. Clin. Exp. Res. 18, 640-643.
143. Thomasson, H. R., Edenberg, H. J., Crabb, D. W., et al. (1991) Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am. J. Hum. Genet. 48, 677-681.
144. Thorsell, A., Rimondi, R., Heilig, M. (2002) Blockade of central neuropeptide Y (NPY) Y2 receptors reduces ethanol self-administration in rats. Neurosci. Lett. 332, 1-4.
145. Tiihonen, J., Hallikainen, T., Lachman, H., et al. (1999) Association between the functional variant of the catechol-O-methyltransferase (COMT) gene and type 1 alcoholism. Mol. Psychiatry 4, 286-289.
146. Town, T., Abdullah, L., Crawford, F., et al. (1999) Association of a functional mu-opioid receptor allele (+118A) with alcohol dependency. Am. J. Med. Genet. 88, 458-461.
147. Tsuang, M. T., Lyons, M. J., Meyer, J. M., et al. (1998) Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch. Gen. Psychiatry 55, 967-972.
148. Tyndale, R. F. (2003) Genetics of alcohol and tobacco use in humans. Ann. Med. 35, 94-121.
149. Tyndale, R. F., Droll, K. P., Sellers, E. M. (1997) Genetically deficient CYP2D6 metabolism provides protection against oral opiate dependence. Pharmacogenetics 7, 375-379.
150. Ueno, S., Nakamura, M., Mikami, M., et al. (1999) Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism. Mol. Psychiatry 4, 552-557.
151. Uhl, G. R., Liu, Q. R., Walther, D., Hess, J., Naiman, D. (2001) Polysubstance abuse-vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. Am. J. Hum. Genet. 69, 1290-1300.
152. Vandenbergh, D. J., Rodriguez, L. A., Hivert, E., et al. (2000) Long forms of the dopamine receptor (DRD4) gene VNTR are more prevalent in substance abusers: no interaction with functional/alleles of the catechol-o-methyltransferase (COMT) gene. Am. J. Med. Genet. 96, 678-683.
153. Van Tol, H. H., Wu, C. M., Guan, H. C., et al. (1992) Multiple dopamine D4 receptor variants in the human population. Nature 358, 149-152.
154. Vanyukov, M. M., Moss, H. B., Yu, L. M., Tarter, R. E., Deka, R. (1995) Preliminary evidence for an association of a dinucleotide repeat polymorphism at the MAOA gene with early onset alcoholism/substance abuse. Am. J. Med. Genet. 60, 122-126.
155. Wall, T. L., Carr, L. G., Ehlers, C. L. (2003) Protective association of genetic variation in alcohol dehydrogenase with alcohol dependence in Native American Mission Indians. Am. J. Psychiatry 160, 41-46.
156. Wall, T. L., Garcia-Andrade, C., Thomasson, H. R., Cole, M., Ehlers, C. L. (1996) Alcohol elimination in Native American Mission Indians: an investigation of interindividual variation. Alcohol. Clin. Exp. Res. 20, 1159-1164.
157. Wand, G. S., McCaul, M., Yang, X., et al. (2002) The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade. Neuropsychopharmacology 26, 106-114.
158. Wang, D., Quillan, J. M., Winas, K., Lucan, J. L., Sadee, W. (2001a) Single nucleotide polymorphisms in the human mu opioid receptor alter basal G protein coupling and calmodulin binding. J. Biol. Chem. 276, 34624-34630.
159. Wang, T., Franke, P., Neidt, H., et al. (2001b) Association study of the low-activity allele of catechol-O-methyltransferase and alcoholism using a family-based approach. Mol. Psychiatry 6, 109-111.
160. n repeat at its gene locus in healthy individuals. Hum. Genet. 99, 52-55.
161. Weinshilboum, R. M. (1974) Serum dopamine β-hydroxylase. Pharmacol. Rev. 30, 133-166.
162. Weinshilboum, R. M., and Raymond, F. A. (1977) Inheritance of low erythrocyte catechol-o-methyltransferase activity in man. Am. J. Hum. Genet. 29, 125-135.
163. Wendel, B., and Hoehe, M. R. (1998) The human mu opioid receptor gene 5′ regulatory and intronic sequences. J. Mol. Med. 76, 525-532.
164. Whitfield, J. B. (1997) Meta-analysis of the effects of alcohol dehydrogenase genotype on alcohol dependence and alcoholic liver disease. Alcohol Alcohol. 32, 613-619.
165. Wilson, A. F., Elston, R. C., Siervogel, R. M., Tran, L. D. (1988) Linkage of a gene regulating dopamine β-hydroxylase activity and the ABO blood group locus. Am. J. Hum. Genet. 42, 160-166.
166. Yasunami, M., Kikuchi, I., Sarapata, D., Yoshida, A. (1990) The human class I alcohol dehydrogenase gene cluster: three genes are tandemly organized in an 80-kb-long segment of the genome. Genomics 7, 152-158.
167. Yoshida, A., Hsu, L. C., Yasunami, M. (1991) Genetics of human alcohol-metabolizing enzymes. Prog. Nucleic Acid Res. Mol. Biol. 40, 255-287.
168. Yoshida, A., Huang, I. Y., Ikawa, M. (1984) Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals. Proc. Natl. Acad. Sci. USA. 81, 258-261.
169. Zabetian, C. P., Anderson, G. M., Buxbaum, S. G., et al. (2001) A quantitative-trait analysis of human plasma-dopamine β-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am. J. Hum. Genet. 68, 515-522.
170. Zhang, Y., Schlussmen, S. D., Ho, A., Kreek, M. J. (2003) Effect of chronic "binge cocaine" on basal levels and cocaine-induced increases of dopamine in caudate putamen and nucleus accumbens of C57BL/6J and 129/J mice. Synapse 50, 191-199.
171. Zhu, G., Pollak, L., Mottagui-Tabar, S., et al. (2003) NPY leu7pro and alcohol dependence in Finnish and Swedish populations. Alcohol. Clin. Exp. Res. 27, 19-24.
172. Zimprich, A., Kraus, J., Wöltje M., Mayer, P., Rauch, E., Höllt V. (2000) An allelic variation in the human prodynorphin gene promoter alters stimulus-induced expression. J. Neurochem. 74, 472-477.